Endocrinology is a field with strong female representation today, with women making up 70% of all endocrinologists in training (Pelley et al., 2016). However, for much of the 20th century, endocrinology, like most areas of medicine, was male dominated and exclusionary toward women seeking to enter the discipline. Among the few women who successfully broke...
Endocrine Society Supports EPA Rule Regulating “Forever Chemicals” in Drinking Water
The Endocrine Society supports a new U.S. Environmental Protection Agency (EPA) rule which includes provisions to regulate several per- and polyfluoroalkyl substances (PFAS)—including PFOA and PFOS—found in our drinking water. The proposed regulation sets an aggressive limit for these PFAS and their mixtures and acknowledges effects at extremely low levels by proposing a health based...
More than 30,000 International Endocrinologists Urge Brussels to Take Action on REACH Revision
On March 14, a broad coalition of over 30,000 European and international endocrine experts have called on EU legislators to publish the revised REACH proposal without any further delay, and no later than June 2023. Citing the urgent and immediate need to minimize exposure to Endocrine Disrupting Chemicals (EDCs) in the interest of public health,...
A Determination to Succeed: The Remarkable Life and Career of Rosalyn Yalow, PhD
John Newell-Price, MD, PhD, Elected 2024 – 2025 Endocrine Society President
Endocrine Society members elected John Newell-Price, MD, PhD, FRCP, as its 2024-2025 President. He will serve as President-Elect for a year beginning in June 2023 before becoming President in June 2024. Newell-Price is professor of endocrinology at the University of Sheffield in Sheffield, United Kingdom. He also is head of the Endocrinology Service at the...
Remembering Carole Mendelson: A Model of Grace, Grit, and Intellect
Endocrine Society Applauds Eli Lilly’s Efforts to Lower Insulin Costs
Monthly price caps should be available to everyone who depends on insulin The Endocrine Society commends Eli Lilly and Company for taking steps to reduce insulin prices and make insulin affordable for more people with diabetes. Eli Lilly’s announcement to cut insulin prices by 70% and extend the $35 per month insulin cap to people...